LIFTMOR bone-loading protocol for osteoporosis in older adults

Bone mineral density declines in all adults after peak bone mass is reached in early adulthood, but the trajectory steepens sharply in women after menopause and accelerates in men after age 65. The consequence — osteoporosis — affects one in two women and one in three men over 60 in Australia, and low bone density is the dominant modifiable risk factor for fragility fractures of the hip, wrist, and vertebral column. Hip fractures carry a one-year mortality rate of 20–30% and a substantial long-term disability burden; this is not a cosmetic problem. Despite decades of public messaging to “walk more and drink milk,” the skeletal response to walking and low-load resistance exercise is negligible in people with existing bone loss. The evidence now points clearly in another direction: supervised high-intensity resistance and impact training produces bone mineral density gains that walking simply cannot achieve.

A. Core clinical — the AU general-practice framework

Understanding bone adaptation in clinical terms. Bone is not a static mineral reservoir; it is a living tissue that continuously remodels in response to mechanical strain. Harold Frost’s mechanostat model — refined across three decades of cortical and trabecular biomechanics research — holds that bone formation is triggered when habitual loading strains exceed a formation threshold of roughly 1,500–3,000 microstrain, and that chronic strains below a lower resorption threshold drive net bone loss. Walking on flat ground generates approximately 400–700 microstrain in the femur — below the formation threshold in most circumstances. Resistance exercise at 85% of 1RM produces 2,000–4,000 microstrain; drop landings generate peak strains of 3,000–6,000 microstrain within 50–100 milliseconds. The cellular signal is amplified by osteocytes — terminally differentiated bone cells embedded throughout the mineralised matrix — via mechanosensitive Piezo1 calcium channels and downstream Wnt/β-catenin signalling that recruits osteoblasts to lay down new matrix.

The LIFTMOR protocol. The LIFTMOR (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation) supervised exercise programme was developed by Professor Belinda Beck and colleagues at Griffith University and tested in the LIFTMOR trial (Watson 2018, JBMR; n=101 postmenopausal women with osteoporosis or osteopenia). The core protocol:

Component	Specification
Frequency	2 sessions per week
Duration	8 months minimum (ongoing thereafter)
Exercises	Deadlift, overhead press, back squat
Load	≥85% of 1RM (5 sets × 5 repetitions)
Impact component	50 supervised repetitions per session (jumping chin-ups + drop landings from 0.4 m box)
Supervision ratio	≤1:8 (participant:staff) for the first 12+ weeks
Instructor qualification	Onero-credentialled or LIFTMOR-trained AEP or physiotherapist

The LIFTMOR-M trial (Harding 2020, JBMR) extended the protocol to middle-aged and older men and confirmed BMD gains in both the lumbar spine and femoral neck region, with additional adaptations for male biomechanics.

Screening and contraindications. Before referral to an LIFTMOR-trained AEP, the GP role is to:

1. Order a DXA scan (MBS item 12306 — eligible for postmenopausal women, men ≥70, and younger adults with risk factors including glucocorticoid use, prior fragility fracture, or clinical risk factors) to document baseline T-scores and site-specific BMD.
2. Calculate fracture risk using the FRAX tool (shef.ac.uk/FRAX) or the Garvan Fracture Risk Calculator (garvan.org.au) incorporating DXA results and clinical variables.
3. Screen absolute contraindications (see Osteoporosis Australia clinical guide):

Contraindication	Rationale
T-score < −3.5 at any site	Insufficient bone reserve for high-load exercise; refer to LIFTMOR-i (vertebral) or modified programme
Fragility fracture within 12 weeks	Healing bone at high fracture site risk; delay until healed and cleared
Vertebral fracture (established)	High-velocity spinal loading contraindicated; LIFTMOR-i IAC modification required
Resting BP >160/100 mmHg (systolic/diastolic)	Valsalva manoeuvre during heavy lifting causes acute pressure spikes
Severe ischaemic heart disease (NYHA III–IV)	High-intensity effort exceeds safe cardiac output capacity
Uncontrolled cardiac arrhythmia	Exercise-triggered risk; cardiological clearance first

4. Consider relative contraindications requiring individualised assessment: hypertension on medication (cleared if controlled <160/100 at rest), chronic joint conditions (movement modifications available), severe kyphosis (modified programme).
5. Review medications. Note use of antiresorptives (bisphosphonates, denosumab) and anabolic agents (teriparatide, romosozumab) — exercise is complementary, not a reason to cease pharmacotherapy in high-risk individuals. Corticosteroid-induced osteoporosis patients are eligible for LIFTMOR if otherwise screened clear.

Nutritional co-interventions. Bone-loading exercise does not build bone in a nutrient-deficient environment. Ensure:

• Protein: ≥1.2 g/kg/day (PROT-AGE consensus) — adequate amino acid substrate for bone matrix and muscle repair.
• Calcium: 1,300 mg/day for women over 50 and men over 70 (from food first; supplement only if dietary intake is insufficient). Calcium supplements carry a modest but real cardiovascular signal in excess; food sources are preferred.
• Vitamin D: serum 25-OH-D ≥50 nmol/L — essential for calcium absorption and osteoblast function. Supplement 1,000–2,000 IU/day if deficient; recheck in 3 months.

B. Evidence appraisal — what the LIFTMOR trials actually showed

LIFTMOR RCT (Watson 2018, J Bone Miner Res; n=101):

Outcome	LIFTMOR (HIIT+impact)	Active control (home exercise)	p-value
Lumbar spine BMD change	+2.9%	−1.2%	<0.001
Femoral neck BMD change	+0.3%	−1.9%	0.004
Tibial cortical thickness	+3.2%	−0.3%	<0.001
Grip strength	+13.4%	+1.2%	0.003
Functional performance (SPPB)	Improved	Minimal change	<0.05

Zero serious adverse events were attributed to the intervention across 8 months. Three non-serious adverse events occurred (two minor muscle strains, one bruise), compared with one in controls.

Strengths of the evidence:

• RCT design with allocation concealment and intention-to-treat analysis.
• Supervised, manualised protocol with fidelity monitoring — what was tested is what is recommended.
• Clinically meaningful BMD changes at both priority fracture sites (spine and hip).
• LIFTMOR-M confirmed generalisability to men (Harding 2020).
• Independent replication of high-load resistance superiority over low-load exercise exists in multiple systematic reviews (e.g. Nikander 2010, BMC Med).

Limitations and caveats:

• Most participants were recruited from the community (motivated, relatively mobile); generalisability to frail aged-care populations is uncertain.
• 8-month trial; long-term fracture outcomes (not surrogate BMD) have not been measured in a sufficiently powered RCT for this specific protocol.
• The “home exercise” active control was genuinely active — the comparison is not against sedentary behaviour.
• The ESSA position statement on exercise and osteoporosis (2018) grades high-load progressive resistance training for bone as Level I evidence (systematic reviews of RCTs), the highest available designation.

Where evidence is weaker: jump landing mechanics in people with severe osteoporosis or established vertebral fracture — these groups were excluded from LIFTMOR. The LIFTMOR-i modification (Impact Adaptive Cardiovascular) exists for this cohort, but published trial evidence is less mature.

C. Practical protocol delivery — what to expect session to session

Initiating referral. A GP management plan (GPCCMP, MBS item 721) enables chronic disease management (CDM) referral to an accredited exercise physiologist (AEP) under MBS item 10953 (5 AEP visits per calendar year, combined with allied health under a Team Care Arrangement). This is the standard pathway. A standard GP referral (without a CDM plan) also works and gives the AEP more flexibility in session scheduling, though without Medicare rebates.

Onero-credentialled clinics. The Onero network trains AEPs and physiotherapists in the LIFTMOR protocol and maintains a clinic directory. Not all exercise physiologists outside this network are trained in LIFTMOR-specific load progression and impact programming; asking the referring AEP specifically about their LIFTMOR or bone-loading training is reasonable.

Session structure (typical):

1. Warm-up: 5 minutes aerobic, joint mobility.
2. Technical lift teaching (first 2–4 weeks): loads begin lighter (around 60–70% 1RM) while form is established for the three core lifts.
3. Progressive load increase toward ≥85% 1RM by weeks 4–6 in compliant participants.
4. Impact component: begins with step-downs before progressing to drop landings; jumping chin-ups begin with band-assisted versions as needed.
5. Cool-down, load recording.

The 80-plus cohort. Adults over 80 are not automatically excluded, but the LIFTMOR protocol’s jump landing component poses a fall risk in those with significant balance impairment or lower-limb weakness. In this group, an AEP typically uses power training as the primary bone stimulus: moderate loads (40–60% 1RM) performed at maximum intentional velocity. The shorter ground contact time and higher peak forces of fast, purposeful movements generate meaningful osteogenic strain without the fall-risk demands of drop landings. Balance training (Otago programme or equivalent) runs concurrently.

D. Australian operations — how to access this pathway

Step-by-step AU access pathway:

1. GP assessment visit (MBS item 23/36/44): review DXA results, calculate FRAX/Garvan risk, screen contraindications, discuss options including exercise and pharmacotherapy.
2. DXA scan (MBS item 12306) if not done within 24 months: requested by GP; bulk-billed at most DXA services. Results in DEXA T-score, Z-score, and site-specific BMD.
3. Create a chronic disease care plan if three or more chronic conditions (or osteoporosis as a standalone condition in high-risk individuals): GPCCMP (MBS item 965/967 — both GP item and care plan), which enables the Team Care Arrangement and AEP/dietitian referrals.
4. Refer to Onero-credentialled or LIFTMOR-trained AEP (MBS item 10953 — 5 combined allied health visits per calendar year under TCA; an additional 5 may be available on clinical review). Find local practitioners at onero.online.
5. Bone pharmacotherapy review: if FRAX or Garvan 10-year major osteoporotic fracture risk ≥20% (high risk), discuss antiresorptive therapy with the patient. Bisphosphonates (alendronate, risedronate) are PBS-subsidised with a valid DXA result meeting the PBS authority criteria.
6. Review at 12 months: repeat DXA if Medicare-eligible (annual DXA is funded in high-risk patients on treatment). Assess adherence, load progression, nutritional targets.

Telehealth options. AEP supervision for LIFTMOR requires in-person attendance — technique and load assessment cannot be safely done remotely for high-load barbell work. Telehealth GP reviews (MBS items 91790/91891) are appropriate for interim monitoring between in-person appointments.

Cost context. A typical AEP session in 2026 costs AUD 80–130. With MBS rebate under TCA (AEP item 10953), the patient rebate is approximately AUD 57 per session. Gym membership for access to a barbell squat rack adds AUD 20–60/month; many Onero clinics have their own dedicated equipment.

E. Special populations

Postmenopausal women. The primary LIFTMOR trial population. Women in the first decade post-menopause are experiencing the steepest period of bone loss and are most likely to show the greatest absolute BMD response to high-intensity loading.

Older men. Men lose bone more slowly than women and typically present later. The LIFTMOR-M trial confirmed that high-intensity loading produces BMD gains in men with osteopenia or osteoporosis, with a similar protocol. Testosterone deficiency (hypogonadism) is an important risk factor to assess; men with low testosterone may need concurrent endocrine management.

People on corticosteroids. Glucocorticoid-induced osteoporosis (GIOP) is the most common secondary cause of osteoporosis in younger adults. These individuals are LIFTMOR-eligible if they pass the standard screening, but they often require concurrent pharmacotherapy (alendronate or risedronate are PBS-subsidised for GIOP) because exercise alone is unlikely to overcome the osteoblast-suppressive effect of ongoing corticosteroid exposure.

People with type 2 diabetes. T2DM is associated with increased fracture risk even at normal BMD (bone quality is impaired independently of density). High-intensity resistance exercise improves both glycaemic control and bone quality markers. No LIFTMOR-specific contraindication applies, but blood glucose monitoring before and after sessions is recommended during the first 4 weeks of high-intensity training.

Frail adults and aged-care residents. The standard LIFTMOR protocol is not appropriate for frail or institutionalised older adults. Well-studied alternatives include the Vivifrail programme and balance-and-resistance programmes for aged care. Falls prevention exercise (including balance training, hip protector use) is the more appropriate priority in this group.

When to escalate

Escalate to specialist care or review the management plan if any of the following occur:

• New back pain during or after a training session — assess for vertebral fracture before continuing high-load exercise.
• Resting blood pressure >160/100 mmHg at any point during the programme — review antihypertensive therapy before continuing.
• New chest pain or exertional dyspnoea — cease training, refer for cardiac evaluation.
• T-score worsens by more than 5% at repeat DXA despite 12 months of adherent training — consider pharmacotherapy escalation or review secondary causes (malabsorption, medication, hormonal).
• Three or more fragility fractures — refer to specialist bone health service (endocrinology or rheumatology with bone sub-specialty interest).
• Patient is unable to achieve ≥60% 1RM loading despite supervised progression — consider modified protocol, investigate pain drivers, assess for undisclosed vertebral fracture.

What this article is and is not

This article summarises the clinical evidence and Australian operational pathway for high-intensity bone-loading exercise in the management of osteoporosis and osteopenia. It is intended to support conversations between patients and their GP or treating AEP; it does not replace an individualised clinical assessment, DXA interpretation, fracture risk calculation, or supervised exercise prescription. The LIFTMOR protocol carries real risks in unprescreened individuals — the safety record in the trials comes from careful screening and qualified supervision, not from the exercises themselves being inherently safe at any load in any person. Do not begin high-intensity barbell training or drop landings for bone health without a DXA result, a GP assessment, and an AEP or physiotherapist who is trained in bone-loading exercise.

---

Sources cited

1. Watson SL, et al. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. J Bone Miner Res. 2018;33(2):211–220. doi:10.1002/jbmr.3284
2. Harding AT, et al. The effects of supervised high-intensity resistance and impact training or machine-based isometric training on regional bone geometry and strength in middle-aged and older men with low bone mass: the LIFTMOR-M semi-randomized controlled trial. J Bone Miner Res. 2020;35(8):1481–1493. doi:10.1002/jbmr.4010
3. Frost HM. Bone’s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275(2):1081–1101. doi:10.1002/ar.a.10119
4. Nikander R, et al. Targeted exercise against osteoporosis: a systematic review and meta-analysis for optimising bone strength throughout life. BMC Med. 2010;8:47. doi:10.1186/1741-7015-8-47
5. Osteoporosis Australia. Osteoporosis — a guide to diagnosis, prevention and management. 2022. osteoporosis.org.au
6. RACGP. Osteoporosis in general practice — a guide for GPs. Royal Australian College of General Practitioners, 2020. racgp.org.au
7. Exercise and Sports Science Australia (ESSA). Position statement: exercise and osteoporosis. 2018. essa.org.au
8. Onero. Bone-loading exercise programme. 2024. onero.online
9. Better Health Channel. Osteoporosis and exercise. Victoria State Government, 2023. betterhealth.vic.gov.au
10. HealthDirect. Osteoporosis. Australian Government, 2024. healthdirect.gov.au